Additionally, inhibition of various other pathways, which can be influenced by CD40 stimulation, had no impact on the CD40L mediated rescue of REC-1 cells and therefore supports the protective role of alternative NFκB pathway activity against BCR inhibitors in MCL. Here, CD40 is linked to mantle cell lymphoma.